Screener
Recursion Pharmaceuticals, Inc. RXRX Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
FAQ
- What is Recursion Pharmaceuticals, Inc.'s return on invested capital?
- Recursion Pharmaceuticals, Inc. (RXRX) reported return on invested capital of -116.4% in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s return on invested capital changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s return on invested capital increased by 35.7% year-over-year, from -181.1% to -116.4%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Recursion Pharmaceuticals, Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude